Global Antibodies for Research Market Growth 2025-2031--LP INFORMATION, INC.

Global Antibodies for Research Market Growth 2025-2031

Product Code: 1480804

Industry: Medical Care

Published: Apr 10,2025

Pages: 129

Delivery Time: 2-3 business days

Global Antibodies for Research Market Growth 2025-2031

Product Code: 1480804

Industry: Medical Care

Published: Apr 10,2025

Pages: 129

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Antibodies for Research market size is predicted to grow from US$ 1655 million in 2025 to US$ 2228 million in 2031; it is expected to grow at a CAGR of 5.1% from 2025 to 2031.

Research antibodies are divided into monoclonal antibodies and polyclonal antibodies. Monoclonal antibodies, also called mAbs, are laboratory-made antibodies that bind to specific targets in the body, such as antigens on the surface of cancer cells. There are several types of monoclonal antibodies, and each mAb is designed to bind a single antigen. They can be used alone or in combination with other drugs to deliver drugs, toxins or radioactive substances directly to cancer cells.

Polyclonal antibody, also known as "polyclonal antibody" (Polyclonal Antibody), is an antibody mixture containing multiple types of antibodies. The "poly" in its name refers to the mixture of antibodies produced by different types of plasma cells.

Rising R&D activities in neurological, oncology, and stem cell research, increasing prevalence of cancer and infectious diseases, growing demand for antibodies, and increasing regulation across the biopharmaceutical industry are the key factors driving the research-based antibodies market revenue.

LP Information, Inc. (LPI) ' newest research report, the “Antibodies for Research Industry Forecast” looks at past sales and reviews total world Antibodies for Research sales in 2024, providing a comprehensive analysis by region and market sector of projected Antibodies for Research sales for 2025 through 2031. With Antibodies for Research sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antibodies for Research industry.

This Insight Report provides a comprehensive analysis of the global Antibodies for Research landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antibodies for Research portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antibodies for Research market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antibodies for Research and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antibodies for Research.

This report presents a comprehensive overview, market shares, and growth opportunities of Antibodies for Research market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Monoclonal

    Polyclonal

Segmentation by Application:

    Oncology

    Neurobiology

    Immunology

    Others

This report also splits the market by region:

    Americas

    United States

    Canada

    Mexico

    Brazil

    APAC

    China

    Japan

    Korea

    Southeast Asia

    India

    Australia

    Europe

    Germany

    France

UK

    Italy

    Russia

    Middle East & Africa

    Egypt

    South Africa

    Israel

    Turkey

    GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    Merck

    Johnson and Johnson Services

    Eli Lilly and Company

    Bio-Rad Laboratories, Inc

    Cell Signalling Technology

    PerkinEImer

    Rockland Immunochemicals

    Novartis

BD

    Abcam

    Kamiya Biomedical

    AMSBIO

    Thermo Fisher Scientific

    GeneTex

MCE

    Shanghai Yanmai Biotechnology

    Shanghai LONG ISLAND Antibody Diagnostica

    SUNSHINE GUOJIAN PHARMACEUTICAL

    Shanghai Junshi Biosciences

Key Questions Addressed in this Report

What is the 10-year outlook for the global Antibodies for Research market?

What factors are driving Antibodies for Research market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Antibodies for Research market opportunities vary by end market size?

How does Antibodies for Research break out by Type, by Application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Antibodies for Research Annual Sales 2020-2031
        2.1.2 World Current & Future Analysis for Antibodies for Research by Geographic Region, 2020, 2024 & 2031
        2.1.3 World Current & Future Analysis for Antibodies for Research by Country/Region, 2020, 2024 & 2031
    2.2 Antibodies for Research Segment by Type
        2.2.1 Monoclonal
        2.2.2 Polyclonal
    2.3 Antibodies for Research Sales by Type
        2.3.1 Global Antibodies for Research Sales Market Share by Type (2020-2025)
        2.3.2 Global Antibodies for Research Revenue and Market Share by Type (2020-2025)
        2.3.3 Global Antibodies for Research Sale Price by Type (2020-2025)
    2.4 Antibodies for Research Segment by Application
        2.4.1 Oncology
        2.4.2 Neurobiology
        2.4.3 Immunology
        2.4.4 Others
    2.5 Antibodies for Research Sales by Application
        2.5.1 Global Antibodies for Research Sale Market Share by Application (2020-2025)
        2.5.2 Global Antibodies for Research Revenue and Market Share by Application (2020-2025)
        2.5.3 Global Antibodies for Research Sale Price by Application (2020-2025)

3 Global by Company
    3.1 Global Antibodies for Research Breakdown Data by Company
        3.1.1 Global Antibodies for Research Annual Sales by Company (2020-2025)
        3.1.2 Global Antibodies for Research Sales Market Share by Company (2020-2025)
    3.2 Global Antibodies for Research Annual Revenue by Company (2020-2025)
        3.2.1 Global Antibodies for Research Revenue by Company (2020-2025)
        3.2.2 Global Antibodies for Research Revenue Market Share by Company (2020-2025)
    3.3 Global Antibodies for Research Sale Price by Company
    3.4 Key Manufacturers Antibodies for Research Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Antibodies for Research Product Location Distribution
        3.4.2 Players Antibodies for Research Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.6 New Products and Potential Entrants
    3.7 Market M&A Activity & Strategy

4 World Historic Review for Antibodies for Research by Geographic Region
    4.1 World Historic Antibodies for Research Market Size by Geographic Region (2020-2025)
        4.1.1 Global Antibodies for Research Annual Sales by Geographic Region (2020-2025)
        4.1.2 Global Antibodies for Research Annual Revenue by Geographic Region (2020-2025)
    4.2 World Historic Antibodies for Research Market Size by Country/Region (2020-2025)
        4.2.1 Global Antibodies for Research Annual Sales by Country/Region (2020-2025)
        4.2.2 Global Antibodies for Research Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Antibodies for Research Sales Growth
    4.4 APAC Antibodies for Research Sales Growth
    4.5 Europe Antibodies for Research Sales Growth
    4.6 Middle East & Africa Antibodies for Research Sales Growth

5 Americas
    5.1 Americas Antibodies for Research Sales by Country
        5.1.1 Americas Antibodies for Research Sales by Country (2020-2025)
        5.1.2 Americas Antibodies for Research Revenue by Country (2020-2025)
    5.2 Americas Antibodies for Research Sales by Type (2020-2025)
    5.3 Americas Antibodies for Research Sales by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Antibodies for Research Sales by Region
        6.1.1 APAC Antibodies for Research Sales by Region (2020-2025)
        6.1.2 APAC Antibodies for Research Revenue by Region (2020-2025)
    6.2 APAC Antibodies for Research Sales by Type (2020-2025)
    6.3 APAC Antibodies for Research Sales by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Antibodies for Research by Country
        7.1.1 Europe Antibodies for Research Sales by Country (2020-2025)
        7.1.2 Europe Antibodies for Research Revenue by Country (2020-2025)
    7.2 Europe Antibodies for Research Sales by Type (2020-2025)
    7.3 Europe Antibodies for Research Sales by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Antibodies for Research by Country
        8.1.1 Middle East & Africa Antibodies for Research Sales by Country (2020-2025)
        8.1.2 Middle East & Africa Antibodies for Research Revenue by Country (2020-2025)
    8.2 Middle East & Africa Antibodies for Research Sales by Type (2020-2025)
    8.3 Middle East & Africa Antibodies for Research Sales by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Antibodies for Research
    10.3 Manufacturing Process Analysis of Antibodies for Research
    10.4 Industry Chain Structure of Antibodies for Research

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Antibodies for Research Distributors
    11.3 Antibodies for Research Customer

12 World Forecast Review for Antibodies for Research by Geographic Region
    12.1 Global Antibodies for Research Market Size Forecast by Region
        12.1.1 Global Antibodies for Research Forecast by Region (2026-2031)
        12.1.2 Global Antibodies for Research Annual Revenue Forecast by Region (2026-2031)
    12.2 Americas Forecast by Country (2026-2031)
    12.3 APAC Forecast by Region (2026-2031)
    12.4 Europe Forecast by Country (2026-2031)
    12.5 Middle East & Africa Forecast by Country (2026-2031)
    12.6 Global Antibodies for Research Forecast by Type (2026-2031)
    12.7 Global Antibodies for Research Forecast by Application (2026-2031)

13 Key Players Analysis
    13.1 Merck
        13.1.1 Merck Company Information
        13.1.2 Merck Antibodies for Research Product Portfolios and Specifications
        13.1.3 Merck Antibodies for Research Sales, Revenue, Price and Gross Margin (2020-2025)
        13.1.4 Merck Main Business Overview
        13.1.5 Merck Latest Developments
    13.2 Johnson and Johnson Services
        13.2.1 Johnson and Johnson Services Company Information
        13.2.2 Johnson and Johnson Services Antibodies for Research Product Portfolios and Specifications
        13.2.3 Johnson and Johnson Services Antibodies for Research Sales, Revenue, Price and Gross Margin (2020-2025)
        13.2.4 Johnson and Johnson Services Main Business Overview
        13.2.5 Johnson and Johnson Services Latest Developments
    13.3 Eli Lilly and Company
        13.3.1 Eli Lilly and Company Company Information
        13.3.2 Eli Lilly and Company Antibodies for Research Product Portfolios and Specifications
        13.3.3 Eli Lilly and Company Antibodies for Research Sales, Revenue, Price and Gross Margin (2020-2025)
        13.3.4 Eli Lilly and Company Main Business Overview
        13.3.5 Eli Lilly and Company Latest Developments
    13.4 Bio-Rad Laboratories, Inc
        13.4.1 Bio-Rad Laboratories, Inc Company Information
        13.4.2 Bio-Rad Laboratories, Inc Antibodies for Research Product Portfolios and Specifications
        13.4.3 Bio-Rad Laboratories, Inc Antibodies for Research Sales, Revenue, Price and Gross Margin (2020-2025)
        13.4.4 Bio-Rad Laboratories, Inc Main Business Overview
        13.4.5 Bio-Rad Laboratories, Inc Latest Developments
    13.5 Cell Signalling Technology
        13.5.1 Cell Signalling Technology Company Information
        13.5.2 Cell Signalling Technology Antibodies for Research Product Portfolios and Specifications
        13.5.3 Cell Signalling Technology Antibodies for Research Sales, Revenue, Price and Gross Margin (2020-2025)
        13.5.4 Cell Signalling Technology Main Business Overview
        13.5.5 Cell Signalling Technology Latest Developments
    13.6 PerkinEImer
        13.6.1 PerkinEImer Company Information
        13.6.2 PerkinEImer Antibodies for Research Product Portfolios and Specifications
        13.6.3 PerkinEImer Antibodies for Research Sales, Revenue, Price and Gross Margin (2020-2025)
        13.6.4 PerkinEImer Main Business Overview
        13.6.5 PerkinEImer Latest Developments
    13.7 Rockland Immunochemicals
        13.7.1 Rockland Immunochemicals Company Information
        13.7.2 Rockland Immunochemicals Antibodies for Research Product Portfolios and Specifications
        13.7.3 Rockland Immunochemicals Antibodies for Research Sales, Revenue, Price and Gross Margin (2020-2025)
        13.7.4 Rockland Immunochemicals Main Business Overview
        13.7.5 Rockland Immunochemicals Latest Developments
    13.8 Novartis
        13.8.1 Novartis Company Information
        13.8.2 Novartis Antibodies for Research Product Portfolios and Specifications
        13.8.3 Novartis Antibodies for Research Sales, Revenue, Price and Gross Margin (2020-2025)
        13.8.4 Novartis Main Business Overview
        13.8.5 Novartis Latest Developments
    13.9 BD
        13.9.1 BD Company Information
        13.9.2 BD Antibodies for Research Product Portfolios and Specifications
        13.9.3 BD Antibodies for Research Sales, Revenue, Price and Gross Margin (2020-2025)
        13.9.4 BD Main Business Overview
        13.9.5 BD Latest Developments
    13.10 Abcam
        13.10.1 Abcam Company Information
        13.10.2 Abcam Antibodies for Research Product Portfolios and Specifications
        13.10.3 Abcam Antibodies for Research Sales, Revenue, Price and Gross Margin (2020-2025)
        13.10.4 Abcam Main Business Overview
        13.10.5 Abcam Latest Developments
    13.11 Kamiya Biomedical
        13.11.1 Kamiya Biomedical Company Information
        13.11.2 Kamiya Biomedical Antibodies for Research Product Portfolios and Specifications
        13.11.3 Kamiya Biomedical Antibodies for Research Sales, Revenue, Price and Gross Margin (2020-2025)
        13.11.4 Kamiya Biomedical Main Business Overview
        13.11.5 Kamiya Biomedical Latest Developments
    13.12 AMSBIO
        13.12.1 AMSBIO Company Information
        13.12.2 AMSBIO Antibodies for Research Product Portfolios and Specifications
        13.12.3 AMSBIO Antibodies for Research Sales, Revenue, Price and Gross Margin (2020-2025)
        13.12.4 AMSBIO Main Business Overview
        13.12.5 AMSBIO Latest Developments
    13.13 Thermo Fisher Scientific
        13.13.1 Thermo Fisher Scientific Company Information
        13.13.2 Thermo Fisher Scientific Antibodies for Research Product Portfolios and Specifications
        13.13.3 Thermo Fisher Scientific Antibodies for Research Sales, Revenue, Price and Gross Margin (2020-2025)
        13.13.4 Thermo Fisher Scientific Main Business Overview
        13.13.5 Thermo Fisher Scientific Latest Developments
    13.14 GeneTex
        13.14.1 GeneTex Company Information
        13.14.2 GeneTex Antibodies for Research Product Portfolios and Specifications
        13.14.3 GeneTex Antibodies for Research Sales, Revenue, Price and Gross Margin (2020-2025)
        13.14.4 GeneTex Main Business Overview
        13.14.5 GeneTex Latest Developments
    13.15 MCE
        13.15.1 MCE Company Information
        13.15.2 MCE Antibodies for Research Product Portfolios and Specifications
        13.15.3 MCE Antibodies for Research Sales, Revenue, Price and Gross Margin (2020-2025)
        13.15.4 MCE Main Business Overview
        13.15.5 MCE Latest Developments
    13.16 Shanghai Yanmai Biotechnology
        13.16.1 Shanghai Yanmai Biotechnology Company Information
        13.16.2 Shanghai Yanmai Biotechnology Antibodies for Research Product Portfolios and Specifications
        13.16.3 Shanghai Yanmai Biotechnology Antibodies for Research Sales, Revenue, Price and Gross Margin (2020-2025)
        13.16.4 Shanghai Yanmai Biotechnology Main Business Overview
        13.16.5 Shanghai Yanmai Biotechnology Latest Developments
    13.17 Shanghai LONG ISLAND Antibody Diagnostica
        13.17.1 Shanghai LONG ISLAND Antibody Diagnostica Company Information
        13.17.2 Shanghai LONG ISLAND Antibody Diagnostica Antibodies for Research Product Portfolios and Specifications
        13.17.3 Shanghai LONG ISLAND Antibody Diagnostica Antibodies for Research Sales, Revenue, Price and Gross Margin (2020-2025)
        13.17.4 Shanghai LONG ISLAND Antibody Diagnostica Main Business Overview
        13.17.5 Shanghai LONG ISLAND Antibody Diagnostica Latest Developments
    13.18 SUNSHINE GUOJIAN PHARMACEUTICAL
        13.18.1 SUNSHINE GUOJIAN PHARMACEUTICAL Company Information
        13.18.2 SUNSHINE GUOJIAN PHARMACEUTICAL Antibodies for Research Product Portfolios and Specifications
        13.18.3 SUNSHINE GUOJIAN PHARMACEUTICAL Antibodies for Research Sales, Revenue, Price and Gross Margin (2020-2025)
        13.18.4 SUNSHINE GUOJIAN PHARMACEUTICAL Main Business Overview
        13.18.5 SUNSHINE GUOJIAN PHARMACEUTICAL Latest Developments
    13.19 Shanghai Junshi Biosciences
        13.19.1 Shanghai Junshi Biosciences Company Information
        13.19.2 Shanghai Junshi Biosciences Antibodies for Research Product Portfolios and Specifications
        13.19.3 Shanghai Junshi Biosciences Antibodies for Research Sales, Revenue, Price and Gross Margin (2020-2025)
        13.19.4 Shanghai Junshi Biosciences Main Business Overview
        13.19.5 Shanghai Junshi Biosciences Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Antibodies for Research Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Table 2. Antibodies for Research Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Monoclonal
 Table 4. Major Players of Polyclonal
 Table 5. Global Antibodies for Research Sales by Type (2020-2025) & (mg)
 Table 6. Global Antibodies for Research Sales Market Share by Type (2020-2025)
 Table 7. Global Antibodies for Research Revenue by Type (2020-2025) & ($ million)
 Table 8. Global Antibodies for Research Revenue Market Share by Type (2020-2025)
 Table 9. Global Antibodies for Research Sale Price by Type (2020-2025) & (US$/mg)
 Table 10. Global Antibodies for Research Sale by Application (2020-2025) & (mg)
 Table 11. Global Antibodies for Research Sale Market Share by Application (2020-2025)
 Table 12. Global Antibodies for Research Revenue by Application (2020-2025) & ($ million)
 Table 13. Global Antibodies for Research Revenue Market Share by Application (2020-2025)
 Table 14. Global Antibodies for Research Sale Price by Application (2020-2025) & (US$/mg)
 Table 15. Global Antibodies for Research Sales by Company (2020-2025) & (mg)
 Table 16. Global Antibodies for Research Sales Market Share by Company (2020-2025)
 Table 17. Global Antibodies for Research Revenue by Company (2020-2025) & ($ millions)
 Table 18. Global Antibodies for Research Revenue Market Share by Company (2020-2025)
 Table 19. Global Antibodies for Research Sale Price by Company (2020-2025) & (US$/mg)
 Table 20. Key Manufacturers Antibodies for Research Producing Area Distribution and Sales Area
 Table 21. Players Antibodies for Research Products Offered
 Table 22. Antibodies for Research Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 23. New Products and Potential Entrants
 Table 24. Market M&A Activity & Strategy
 Table 25. Global Antibodies for Research Sales by Geographic Region (2020-2025) & (mg)
 Table 26. Global Antibodies for Research Sales Market Share Geographic Region (2020-2025)
 Table 27. Global Antibodies for Research Revenue by Geographic Region (2020-2025) & ($ millions)
 Table 28. Global Antibodies for Research Revenue Market Share by Geographic Region (2020-2025)
 Table 29. Global Antibodies for Research Sales by Country/Region (2020-2025) & (mg)
 Table 30. Global Antibodies for Research Sales Market Share by Country/Region (2020-2025)
 Table 31. Global Antibodies for Research Revenue by Country/Region (2020-2025) & ($ millions)
 Table 32. Global Antibodies for Research Revenue Market Share by Country/Region (2020-2025)
 Table 33. Americas Antibodies for Research Sales by Country (2020-2025) & (mg)
 Table 34. Americas Antibodies for Research Sales Market Share by Country (2020-2025)
 Table 35. Americas Antibodies for Research Revenue by Country (2020-2025) & ($ millions)
 Table 36. Americas Antibodies for Research Sales by Type (2020-2025) & (mg)
 Table 37. Americas Antibodies for Research Sales by Application (2020-2025) & (mg)
 Table 38. APAC Antibodies for Research Sales by Region (2020-2025) & (mg)
 Table 39. APAC Antibodies for Research Sales Market Share by Region (2020-2025)
 Table 40. APAC Antibodies for Research Revenue by Region (2020-2025) & ($ millions)
 Table 41. APAC Antibodies for Research Sales by Type (2020-2025) & (mg)
 Table 42. APAC Antibodies for Research Sales by Application (2020-2025) & (mg)
 Table 43. Europe Antibodies for Research Sales by Country (2020-2025) & (mg)
 Table 44. Europe Antibodies for Research Revenue by Country (2020-2025) & ($ millions)
 Table 45. Europe Antibodies for Research Sales by Type (2020-2025) & (mg)
 Table 46. Europe Antibodies for Research Sales by Application (2020-2025) & (mg)
 Table 47. Middle East & Africa Antibodies for Research Sales by Country (2020-2025) & (mg)
 Table 48. Middle East & Africa Antibodies for Research Revenue Market Share by Country (2020-2025)
 Table 49. Middle East & Africa Antibodies for Research Sales by Type (2020-2025) & (mg)
 Table 50. Middle East & Africa Antibodies for Research Sales by Application (2020-2025) & (mg)
 Table 51. Key Market Drivers & Growth Opportunities of Antibodies for Research
 Table 52. Key Market Challenges & Risks of Antibodies for Research
 Table 53. Key Industry Trends of Antibodies for Research
 Table 54. Antibodies for Research Raw Material
 Table 55. Key Suppliers of Raw Materials
 Table 56. Antibodies for Research Distributors List
 Table 57. Antibodies for Research Customer List
 Table 58. Global Antibodies for Research Sales Forecast by Region (2026-2031) & (mg)
 Table 59. Global Antibodies for Research Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 60. Americas Antibodies for Research Sales Forecast by Country (2026-2031) & (mg)
 Table 61. Americas Antibodies for Research Annual Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 62. APAC Antibodies for Research Sales Forecast by Region (2026-2031) & (mg)
 Table 63. APAC Antibodies for Research Annual Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 64. Europe Antibodies for Research Sales Forecast by Country (2026-2031) & (mg)
 Table 65. Europe Antibodies for Research Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 66. Middle East & Africa Antibodies for Research Sales Forecast by Country (2026-2031) & (mg)
 Table 67. Middle East & Africa Antibodies for Research Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 68. Global Antibodies for Research Sales Forecast by Type (2026-2031) & (mg)
 Table 69. Global Antibodies for Research Revenue Forecast by Type (2026-2031) & ($ millions)
 Table 70. Global Antibodies for Research Sales Forecast by Application (2026-2031) & (mg)
 Table 71. Global Antibodies for Research Revenue Forecast by Application (2026-2031) & ($ millions)
 Table 72. Merck Basic Information, Antibodies for Research Manufacturing Base, Sales Area and Its Competitors
 Table 73. Merck Antibodies for Research Product Portfolios and Specifications
 Table 74. Merck Antibodies for Research Sales (mg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 75. Merck Main Business
 Table 76. Merck Latest Developments
 Table 77. Johnson and Johnson Services Basic Information, Antibodies for Research Manufacturing Base, Sales Area and Its Competitors
 Table 78. Johnson and Johnson Services Antibodies for Research Product Portfolios and Specifications
 Table 79. Johnson and Johnson Services Antibodies for Research Sales (mg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 80. Johnson and Johnson Services Main Business
 Table 81. Johnson and Johnson Services Latest Developments
 Table 82. Eli Lilly and Company Basic Information, Antibodies for Research Manufacturing Base, Sales Area and Its Competitors
 Table 83. Eli Lilly and Company Antibodies for Research Product Portfolios and Specifications
 Table 84. Eli Lilly and Company Antibodies for Research Sales (mg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 85. Eli Lilly and Company Main Business
 Table 86. Eli Lilly and Company Latest Developments
 Table 87. Bio-Rad Laboratories, Inc Basic Information, Antibodies for Research Manufacturing Base, Sales Area and Its Competitors
 Table 88. Bio-Rad Laboratories, Inc Antibodies for Research Product Portfolios and Specifications
 Table 89. Bio-Rad Laboratories, Inc Antibodies for Research Sales (mg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 90. Bio-Rad Laboratories, Inc Main Business
 Table 91. Bio-Rad Laboratories, Inc Latest Developments
 Table 92. Cell Signalling Technology Basic Information, Antibodies for Research Manufacturing Base, Sales Area and Its Competitors
 Table 93. Cell Signalling Technology Antibodies for Research Product Portfolios and Specifications
 Table 94. Cell Signalling Technology Antibodies for Research Sales (mg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 95. Cell Signalling Technology Main Business
 Table 96. Cell Signalling Technology Latest Developments
 Table 97. PerkinEImer Basic Information, Antibodies for Research Manufacturing Base, Sales Area and Its Competitors
 Table 98. PerkinEImer Antibodies for Research Product Portfolios and Specifications
 Table 99. PerkinEImer Antibodies for Research Sales (mg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 100. PerkinEImer Main Business
 Table 101. PerkinEImer Latest Developments
 Table 102. Rockland Immunochemicals Basic Information, Antibodies for Research Manufacturing Base, Sales Area and Its Competitors
 Table 103. Rockland Immunochemicals Antibodies for Research Product Portfolios and Specifications
 Table 104. Rockland Immunochemicals Antibodies for Research Sales (mg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 105. Rockland Immunochemicals Main Business
 Table 106. Rockland Immunochemicals Latest Developments
 Table 107. Novartis Basic Information, Antibodies for Research Manufacturing Base, Sales Area and Its Competitors
 Table 108. Novartis Antibodies for Research Product Portfolios and Specifications
 Table 109. Novartis Antibodies for Research Sales (mg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 110. Novartis Main Business
 Table 111. Novartis Latest Developments
 Table 112. BD Basic Information, Antibodies for Research Manufacturing Base, Sales Area and Its Competitors
 Table 113. BD Antibodies for Research Product Portfolios and Specifications
 Table 114. BD Antibodies for Research Sales (mg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 115. BD Main Business
 Table 116. BD Latest Developments
 Table 117. Abcam Basic Information, Antibodies for Research Manufacturing Base, Sales Area and Its Competitors
 Table 118. Abcam Antibodies for Research Product Portfolios and Specifications
 Table 119. Abcam Antibodies for Research Sales (mg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 120. Abcam Main Business
 Table 121. Abcam Latest Developments
 Table 122. Kamiya Biomedical Basic Information, Antibodies for Research Manufacturing Base, Sales Area and Its Competitors
 Table 123. Kamiya Biomedical Antibodies for Research Product Portfolios and Specifications
 Table 124. Kamiya Biomedical Antibodies for Research Sales (mg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 125. Kamiya Biomedical Main Business
 Table 126. Kamiya Biomedical Latest Developments
 Table 127. AMSBIO Basic Information, Antibodies for Research Manufacturing Base, Sales Area and Its Competitors
 Table 128. AMSBIO Antibodies for Research Product Portfolios and Specifications
 Table 129. AMSBIO Antibodies for Research Sales (mg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 130. AMSBIO Main Business
 Table 131. AMSBIO Latest Developments
 Table 132. Thermo Fisher Scientific Basic Information, Antibodies for Research Manufacturing Base, Sales Area and Its Competitors
 Table 133. Thermo Fisher Scientific Antibodies for Research Product Portfolios and Specifications
 Table 134. Thermo Fisher Scientific Antibodies for Research Sales (mg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 135. Thermo Fisher Scientific Main Business
 Table 136. Thermo Fisher Scientific Latest Developments
 Table 137. GeneTex Basic Information, Antibodies for Research Manufacturing Base, Sales Area and Its Competitors
 Table 138. GeneTex Antibodies for Research Product Portfolios and Specifications
 Table 139. GeneTex Antibodies for Research Sales (mg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 140. GeneTex Main Business
 Table 141. GeneTex Latest Developments
 Table 142. MCE Basic Information, Antibodies for Research Manufacturing Base, Sales Area and Its Competitors
 Table 143. MCE Antibodies for Research Product Portfolios and Specifications
 Table 144. MCE Antibodies for Research Sales (mg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 145. MCE Main Business
 Table 146. MCE Latest Developments
 Table 147. Shanghai Yanmai Biotechnology Basic Information, Antibodies for Research Manufacturing Base, Sales Area and Its Competitors
 Table 148. Shanghai Yanmai Biotechnology Antibodies for Research Product Portfolios and Specifications
 Table 149. Shanghai Yanmai Biotechnology Antibodies for Research Sales (mg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 150. Shanghai Yanmai Biotechnology Main Business
 Table 151. Shanghai Yanmai Biotechnology Latest Developments
 Table 152. Shanghai LONG ISLAND Antibody Diagnostica Basic Information, Antibodies for Research Manufacturing Base, Sales Area and Its Competitors
 Table 153. Shanghai LONG ISLAND Antibody Diagnostica Antibodies for Research Product Portfolios and Specifications
 Table 154. Shanghai LONG ISLAND Antibody Diagnostica Antibodies for Research Sales (mg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 155. Shanghai LONG ISLAND Antibody Diagnostica Main Business
 Table 156. Shanghai LONG ISLAND Antibody Diagnostica Latest Developments
 Table 157. SUNSHINE GUOJIAN PHARMACEUTICAL Basic Information, Antibodies for Research Manufacturing Base, Sales Area and Its Competitors
 Table 158. SUNSHINE GUOJIAN PHARMACEUTICAL Antibodies for Research Product Portfolios and Specifications
 Table 159. SUNSHINE GUOJIAN PHARMACEUTICAL Antibodies for Research Sales (mg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 160. SUNSHINE GUOJIAN PHARMACEUTICAL Main Business
 Table 161. SUNSHINE GUOJIAN PHARMACEUTICAL Latest Developments
 Table 162. Shanghai Junshi Biosciences Basic Information, Antibodies for Research Manufacturing Base, Sales Area and Its Competitors
 Table 163. Shanghai Junshi Biosciences Antibodies for Research Product Portfolios and Specifications
 Table 164. Shanghai Junshi Biosciences Antibodies for Research Sales (mg), Revenue ($ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 165. Shanghai Junshi Biosciences Main Business
 Table 166. Shanghai Junshi Biosciences Latest Developments


List of Figures
 Figure 1. Picture of Antibodies for Research
 Figure 2. Antibodies for Research Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global Antibodies for Research Sales Growth Rate 2020-2031 (mg)
 Figure 7. Global Antibodies for Research Revenue Growth Rate 2020-2031 ($ millions)
 Figure 8. Antibodies for Research Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 9. Antibodies for Research Sales Market Share by Country/Region (2024)
 Figure 10. Antibodies for Research Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 11. Product Picture of Monoclonal
 Figure 12. Product Picture of Polyclonal
 Figure 13. Global Antibodies for Research Sales Market Share by Type in 2025
 Figure 14. Global Antibodies for Research Revenue Market Share by Type (2020-2025)
 Figure 15. Antibodies for Research Consumed in Oncology
 Figure 16. Global Antibodies for Research Market: Oncology (2020-2025) & (mg)
 Figure 17. Antibodies for Research Consumed in Neurobiology
 Figure 18. Global Antibodies for Research Market: Neurobiology (2020-2025) & (mg)
 Figure 19. Antibodies for Research Consumed in Immunology
 Figure 20. Global Antibodies for Research Market: Immunology (2020-2025) & (mg)
 Figure 21. Antibodies for Research Consumed in Others
 Figure 22. Global Antibodies for Research Market: Others (2020-2025) & (mg)
 Figure 23. Global Antibodies for Research Sale Market Share by Application (2024)
 Figure 24. Global Antibodies for Research Revenue Market Share by Application in 2025
 Figure 25. Antibodies for Research Sales by Company in 2025 (mg)
 Figure 26. Global Antibodies for Research Sales Market Share by Company in 2025
 Figure 27. Antibodies for Research Revenue by Company in 2025 ($ millions)
 Figure 28. Global Antibodies for Research Revenue Market Share by Company in 2025
 Figure 29. Global Antibodies for Research Sales Market Share by Geographic Region (2020-2025)
 Figure 30. Global Antibodies for Research Revenue Market Share by Geographic Region in 2025
 Figure 31. Americas Antibodies for Research Sales 2020-2025 (mg)
 Figure 32. Americas Antibodies for Research Revenue 2020-2025 ($ millions)
 Figure 33. APAC Antibodies for Research Sales 2020-2025 (mg)
 Figure 34. APAC Antibodies for Research Revenue 2020-2025 ($ millions)
 Figure 35. Europe Antibodies for Research Sales 2020-2025 (mg)
 Figure 36. Europe Antibodies for Research Revenue 2020-2025 ($ millions)
 Figure 37. Middle East & Africa Antibodies for Research Sales 2020-2025 (mg)
 Figure 38. Middle East & Africa Antibodies for Research Revenue 2020-2025 ($ millions)
 Figure 39. Americas Antibodies for Research Sales Market Share by Country in 2025
 Figure 40. Americas Antibodies for Research Revenue Market Share by Country (2020-2025)
 Figure 41. Americas Antibodies for Research Sales Market Share by Type (2020-2025)
 Figure 42. Americas Antibodies for Research Sales Market Share by Application (2020-2025)
 Figure 43. United States Antibodies for Research Revenue Growth 2020-2025 ($ millions)
 Figure 44. Canada Antibodies for Research Revenue Growth 2020-2025 ($ millions)
 Figure 45. Mexico Antibodies for Research Revenue Growth 2020-2025 ($ millions)
 Figure 46. Brazil Antibodies for Research Revenue Growth 2020-2025 ($ millions)
 Figure 47. APAC Antibodies for Research Sales Market Share by Region in 2025
 Figure 48. APAC Antibodies for Research Revenue Market Share by Region (2020-2025)
 Figure 49. APAC Antibodies for Research Sales Market Share by Type (2020-2025)
 Figure 50. APAC Antibodies for Research Sales Market Share by Application (2020-2025)
 Figure 51. China Antibodies for Research Revenue Growth 2020-2025 ($ millions)
 Figure 52. Japan Antibodies for Research Revenue Growth 2020-2025 ($ millions)
 Figure 53. South Korea Antibodies for Research Revenue Growth 2020-2025 ($ millions)
 Figure 54. Southeast Asia Antibodies for Research Revenue Growth 2020-2025 ($ millions)
 Figure 55. India Antibodies for Research Revenue Growth 2020-2025 ($ millions)
 Figure 56. Australia Antibodies for Research Revenue Growth 2020-2025 ($ millions)
 Figure 57. China Taiwan Antibodies for Research Revenue Growth 2020-2025 ($ millions)
 Figure 58. Europe Antibodies for Research Sales Market Share by Country in 2025
 Figure 59. Europe Antibodies for Research Revenue Market Share by Country (2020-2025)
 Figure 60. Europe Antibodies for Research Sales Market Share by Type (2020-2025)
 Figure 61. Europe Antibodies for Research Sales Market Share by Application (2020-2025)
 Figure 62. Germany Antibodies for Research Revenue Growth 2020-2025 ($ millions)
 Figure 63. France Antibodies for Research Revenue Growth 2020-2025 ($ millions)
 Figure 64. UK Antibodies for Research Revenue Growth 2020-2025 ($ millions)
 Figure 65. Italy Antibodies for Research Revenue Growth 2020-2025 ($ millions)
 Figure 66. Russia Antibodies for Research Revenue Growth 2020-2025 ($ millions)
 Figure 67. Middle East & Africa Antibodies for Research Sales Market Share by Country (2020-2025)
 Figure 68. Middle East & Africa Antibodies for Research Sales Market Share by Type (2020-2025)
 Figure 69. Middle East & Africa Antibodies for Research Sales Market Share by Application (2020-2025)
 Figure 70. Egypt Antibodies for Research Revenue Growth 2020-2025 ($ millions)
 Figure 71. South Africa Antibodies for Research Revenue Growth 2020-2025 ($ millions)
 Figure 72. Israel Antibodies for Research Revenue Growth 2020-2025 ($ millions)
 Figure 73. Turkey Antibodies for Research Revenue Growth 2020-2025 ($ millions)
 Figure 74. GCC Countries Antibodies for Research Revenue Growth 2020-2025 ($ millions)
 Figure 75. Manufacturing Cost Structure Analysis of Antibodies for Research in 2025
 Figure 76. Manufacturing Process Analysis of Antibodies for Research
 Figure 77. Industry Chain Structure of Antibodies for Research
 Figure 78. Channels of Distribution
 Figure 79. Global Antibodies for Research Sales Market Forecast by Region (2026-2031)
 Figure 80. Global Antibodies for Research Revenue Market Share Forecast by Region (2026-2031)
 Figure 81. Global Antibodies for Research Sales Market Share Forecast by Type (2026-2031)
 Figure 82. Global Antibodies for Research Revenue Market Share Forecast by Type (2026-2031)
 Figure 83. Global Antibodies for Research Sales Market Share Forecast by Application (2026-2031)
 Figure 84. Global Antibodies for Research Revenue Market Share Forecast by Application (2026-2031)

Companies Mentioned

Merck

Johnson and Johnson Services

Eli Lilly and Company

Bio-Rad Laboratories, Inc

Cell Signalling Technology

PerkinEImer

Rockland Immunochemicals

Novartis

Abcam

Kamiya Biomedical

AMSBIO

Thermo Fisher Scientific

GeneTex

MCE

Shanghai Yanmai Biotechnology

Shanghai LONG ISLAND Antibody Diagnostica

SUNSHINE GUOJIAN PHARMACEUTICAL

Shanghai Junshi Biosciences

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff